Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Always work with your functional medicine provider for personalized supplement guidance
AKB-6548: A new hypoxia-inducible factor prolyl hydroxylase inhibitor, increases hemoglobin in chronic kidney disease patients without increasing basal erythropoietin levels [abstract]
Semaglutide adds more GLP-1 activity
A US Food and Drug Administration advisory committee is scheduled to meet in July 2026 to consider whether pharmacies should be permitted to compound and sell seven unapproved peptides, with BPC-157 among them
US$ 25.58
US$ 28.25
US$ 23.62
US$ 20.47
US$ 21.26
US$ 27.41
US$ 28.69
US$ 25.55
US$ 29.62
US$ 28.26
